Browsing by Author Jarzab, Barbara

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2013Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancerClifton-Bligh, Roderick; O'Neill, Christine; Sywak, Mark; Alzahrani, Ali S; Bendlova, Bela; Carson, Kathryn A; Czarniecka, Agnieszka; Elisei, Rossella; et al, Various; Fagin, James; Fugazzola, Laura; Jarzab, Barbara; Mian, Caterina; Puxeddu, Efisio; Robenshtok, Eyal; Tuttle, Michael R; Vianello, Federica; Viola, David; Xing, Mingzhao; Yip, Linwah; Northern Clinical School: Medicine; Northern Clinical School: Surgery; Northern Clinical School: SurgeryAssociation between BRAF V600E mutation and mortality in patients with papillary thyroid cancer, JAMA: The Journal of the American Medical Association, vol.309, 14, 2013,pp 1493-1501
2015A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessmentRobinson, Bruce; Andresen, Corina; Bodenner, Donald; Cabanillas, Maria; et al, Various; Jarzab, Barbara; Martins, Renato; McCaffrey, Judith; Pacini, Furio; Schlumberger, Martin Jean; Shah, Manisha H.; Topliss, Duncan J.; Northern Clinical School: MedicineA phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment, Cancer, vol.121, 16, 2015,pp 2749-2756
2016A Phase II Trial of the Multi-targeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (MTC)Robinson, Bruce; Allison, Roger; Ball, Douglas W.; Cabanillas, Maria; et al, Various; Jarzab, Barbara; Martins, Renato; McCaffrey, Judith; Newbold, Kate; Pacini, Furio; Schlumberger, Martin Jean; Northern Clinical School: MedicineA Phase II Trial of the Multi-targeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (MTC), Clinical Cancer Research, vol.22, 1, 2016,pp 44-53
2012Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III TrialRobinson, Bruce; Baudin, Eric; Dralle, H; Elisei, Rossella; Fagin, James; Gagel, Robert; Jarzab, Barbara; Langmuir, Peter; Read, Jessica; Ryan, Anderson; Santoro, Massimo; Schlumberger, Martin Jean; Vasselli, James; Wells, Jr,Samuel; Northern Clinical School: MedicineVandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial, Journal of Clinical Oncology, vol.30, 2, 2012,pp 134-141